Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Phase 2 Study of JTS-653 in Post‑Herpetic Neuralgia
jRCT2080221142Phase 2
- Sponsor
- Japan Tobacco
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing JTS-653 oral with Placebo oral (2 arms).
02
Drugs
JTS-653
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on jRCT2080221142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221142.